Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease
•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to impro...
Gespeichert in:
Veröffentlicht in: | Gait & posture 2020-10, Vol.82, p.1-5 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5 |
---|---|
container_issue | |
container_start_page | 1 |
container_title | Gait & posture |
container_volume | 82 |
creator | Jeng, Brenda Cederberg, Katie L.J. Lai, Byron Sasaki, Jeffer E. Bamman, Marcas M. Motl, Robert W. |
description | •Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy.
Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD.
Does O2 cost of walking differ between persons with PD and controls matched by age and sex?
The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1).
There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p > 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p < 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1.
Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation. |
doi_str_mv | 10.1016/j.gaitpost.2020.08.108 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7718302</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0966636220304999</els_id><sourcerecordid>2437121023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</originalsourceid><addsrcrecordid>eNqFkU1uFDEQhS0EIkPgCpGXbHrwX7vdGwSKwo8UKSxgwcpy2-WOh257sHsmZMc1cr2cBEeTRLBiVVLVV6-e6iF0QsmaEirfbNajCcs2lWXNCCNrompfPUErqrq-YYz2T9GK9FI2kkt2hF6UsiGECK7Yc3TEmeKSMLlC3y9-XY8Qsa1KOHmc9pCbMadddPjKTD9CHHGIeAu5pFjwVVgu8Rwm1yypmZODbBbAX0yuYAVuf98U7EIBU-AleubNVODVfT1G3z6cfT391JxffPx8-v68saKjS8MG01tSTYLhrVNMtJ4r6T3xpm2lc2IYmJC98NByqEA3CGGJJX4A72Tn-DF6e9Dd7oYZnIW4ZDPpbQ6zydc6maD_ncRwqce0111HFSesCry-F8jp5w7KoudQLEyTiZB2RTPBO8poJSsqD6jNqZQM_vEMJfouF73RD7nou1w0UbWv6uLJ3yYf1x6CqMC7AwD1VfsAWRcbIFpwIYNdtEvhfzf-AG_Tppo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2437121023</pqid></control><display><type>article</type><title>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Jeng, Brenda ; Cederberg, Katie L.J. ; Lai, Byron ; Sasaki, Jeffer E. ; Bamman, Marcas M. ; Motl, Robert W.</creator><creatorcontrib>Jeng, Brenda ; Cederberg, Katie L.J. ; Lai, Byron ; Sasaki, Jeffer E. ; Bamman, Marcas M. ; Motl, Robert W.</creatorcontrib><description>•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy.
Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD.
Does O2 cost of walking differ between persons with PD and controls matched by age and sex?
The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1).
There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p > 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p < 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1.
Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation.</description><identifier>ISSN: 0966-6362</identifier><identifier>EISSN: 1879-2219</identifier><identifier>DOI: 10.1016/j.gaitpost.2020.08.108</identifier><identifier>PMID: 32836026</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Aged ; Cross-Sectional Studies ; Energy expenditure ; Energy Metabolism - physiology ; Female ; Humans ; Male ; Middle Aged ; Oxygen - economics ; Oxygen Consumption - physiology ; Parkinson Disease - economics ; Parkinson Disease - therapy ; Parkinson’s disease ; Rehabilitation ; Walking ; Walking - physiology</subject><ispartof>Gait & posture, 2020-10, Vol.82, p.1-5</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</citedby><cites>FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.gaitpost.2020.08.108$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32836026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jeng, Brenda</creatorcontrib><creatorcontrib>Cederberg, Katie L.J.</creatorcontrib><creatorcontrib>Lai, Byron</creatorcontrib><creatorcontrib>Sasaki, Jeffer E.</creatorcontrib><creatorcontrib>Bamman, Marcas M.</creatorcontrib><creatorcontrib>Motl, Robert W.</creatorcontrib><title>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</title><title>Gait & posture</title><addtitle>Gait Posture</addtitle><description>•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy.
Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD.
Does O2 cost of walking differ between persons with PD and controls matched by age and sex?
The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1).
There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p > 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p < 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1.
Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation.</description><subject>Aged</subject><subject>Cross-Sectional Studies</subject><subject>Energy expenditure</subject><subject>Energy Metabolism - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oxygen - economics</subject><subject>Oxygen Consumption - physiology</subject><subject>Parkinson Disease - economics</subject><subject>Parkinson Disease - therapy</subject><subject>Parkinson’s disease</subject><subject>Rehabilitation</subject><subject>Walking</subject><subject>Walking - physiology</subject><issn>0966-6362</issn><issn>1879-2219</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1uFDEQhS0EIkPgCpGXbHrwX7vdGwSKwo8UKSxgwcpy2-WOh257sHsmZMc1cr2cBEeTRLBiVVLVV6-e6iF0QsmaEirfbNajCcs2lWXNCCNrompfPUErqrq-YYz2T9GK9FI2kkt2hF6UsiGECK7Yc3TEmeKSMLlC3y9-XY8Qsa1KOHmc9pCbMadddPjKTD9CHHGIeAu5pFjwVVgu8Rwm1yypmZODbBbAX0yuYAVuf98U7EIBU-AleubNVODVfT1G3z6cfT391JxffPx8-v68saKjS8MG01tSTYLhrVNMtJ4r6T3xpm2lc2IYmJC98NByqEA3CGGJJX4A72Tn-DF6e9Dd7oYZnIW4ZDPpbQ6zydc6maD_ncRwqce0111HFSesCry-F8jp5w7KoudQLEyTiZB2RTPBO8poJSsqD6jNqZQM_vEMJfouF73RD7nou1w0UbWv6uLJ3yYf1x6CqMC7AwD1VfsAWRcbIFpwIYNdtEvhfzf-AG_Tppo</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Jeng, Brenda</creator><creator>Cederberg, Katie L.J.</creator><creator>Lai, Byron</creator><creator>Sasaki, Jeffer E.</creator><creator>Bamman, Marcas M.</creator><creator>Motl, Robert W.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201001</creationdate><title>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</title><author>Jeng, Brenda ; Cederberg, Katie L.J. ; Lai, Byron ; Sasaki, Jeffer E. ; Bamman, Marcas M. ; Motl, Robert W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-2ba9c0636ea35d8245f386ff0fa556dd4bb24694fe53e5d87b44c0c0fbefd67d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Cross-Sectional Studies</topic><topic>Energy expenditure</topic><topic>Energy Metabolism - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oxygen - economics</topic><topic>Oxygen Consumption - physiology</topic><topic>Parkinson Disease - economics</topic><topic>Parkinson Disease - therapy</topic><topic>Parkinson’s disease</topic><topic>Rehabilitation</topic><topic>Walking</topic><topic>Walking - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jeng, Brenda</creatorcontrib><creatorcontrib>Cederberg, Katie L.J.</creatorcontrib><creatorcontrib>Lai, Byron</creatorcontrib><creatorcontrib>Sasaki, Jeffer E.</creatorcontrib><creatorcontrib>Bamman, Marcas M.</creatorcontrib><creatorcontrib>Motl, Robert W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gait & posture</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jeng, Brenda</au><au>Cederberg, Katie L.J.</au><au>Lai, Byron</au><au>Sasaki, Jeffer E.</au><au>Bamman, Marcas M.</au><au>Motl, Robert W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease</atitle><jtitle>Gait & posture</jtitle><addtitle>Gait Posture</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>82</volume><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>0966-6362</issn><eissn>1879-2219</eissn><abstract>•Persons with Parkinson’s disease had a higher oxygen cost of walking than controls.•Stride length, but not caden, was associated with oxygen cost of walking.•This highlights developing exercise programs to reduce the oxygen cost of walking.•Interventions may target increasing stride length to improve walking economy.
Oxygen (O2) cost of walking is a physiological marker of walking dysfunction and reflects the amount of O2 consumed per kilogram of body weight per unit distance walked. The onset of walking dysfunction (i.e., reduced walking speed and shorter stride length) is commonly observed in Parkinson’s disease (PD), even in the early stages of the disease. However, the O2 cost of walking has not been assessed in persons with PD.
Does O2 cost of walking differ between persons with PD and controls matched by age and sex?
The sample included 31 persons with mild-to-moderate PD (Hoehn and Yahr stages 2–3) and 31 age- and sex-matched controls in this cross-sectional study. O2 consumption (VO2) was measured using a portable indirect calorimetry system during a 6-min period of over-ground walking at a normal comfortable speed, and the O2 cost of walking was calculated based on the ratio of net relative VO2 (ml kg−1 min−1) and speed (m min−1).
There were no differences in resting VO2, steady-state VO2, and over-ground walking speed between persons with PD and controls (p > 0.05). There was a significant difference in the O2 cost of walking between persons with PD and healthy controls (p < 0.01) such that persons with PD had a higher O2 cost of walking. The mean(SD) O2 cost of walking for persons with PD was 0.179 (0.038) ml kg−1 m−1, and the O2 cost of walking for healthy controls was 0.153 (0.024) ml kg−1 m−1.
Persons with PD demonstrated a higher O2 cost of walking compared with controls, and this may reflect worse walking economy in PD. The possibility of worse walking economy under free-living conditions may result in reduced community ambulation and participation.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>32836026</pmid><doi>10.1016/j.gaitpost.2020.08.108</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0966-6362 |
ispartof | Gait & posture, 2020-10, Vol.82, p.1-5 |
issn | 0966-6362 1879-2219 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7718302 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Aged Cross-Sectional Studies Energy expenditure Energy Metabolism - physiology Female Humans Male Middle Aged Oxygen - economics Oxygen Consumption - physiology Parkinson Disease - economics Parkinson Disease - therapy Parkinson’s disease Rehabilitation Walking Walking - physiology |
title | Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson’s disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T08%3A23%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxygen%20cost%20of%20over-ground%20walking%20in%20persons%20with%20mild-to-moderate%20Parkinson%E2%80%99s%20disease&rft.jtitle=Gait%20&%20posture&rft.au=Jeng,%20Brenda&rft.date=2020-10-01&rft.volume=82&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=0966-6362&rft.eissn=1879-2219&rft_id=info:doi/10.1016/j.gaitpost.2020.08.108&rft_dat=%3Cproquest_pubme%3E2437121023%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2437121023&rft_id=info:pmid/32836026&rft_els_id=S0966636220304999&rfr_iscdi=true |